State Mifepristone Regulation Following <i>GenBioPro v Raynes</i>
This Viewpoint discusses the GenBioPro v Raynes decision and what it could mean for other cases challenging medication abortion restrictions on preemption grounds.
Authors
- Patricia J. Zettler (ORCID: https://orcid.org/0000-0001-9114-0735)
- Lewis A. Grossman (ORCID: https://orcid.org/0000-0001-6373-6419)
- Greer Donley (ORCID: https://orcid.org/0000-0001-7680-5962)
Institutions
- University of Pittsburgh (US)
- American University (US)
- The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-12-02
- DOI
- https://doi.org/10.1001/jama.2025.19752
- Citations
- 1
- Primary Topic
- Diverse Scientific and Economic Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.13